IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i23p8847-d452713.html
   My bibliography  Save this article

Risk Factors on the Progression to Clinical Outcomes of COVID-19 Patients in South Korea: Using National Data

Author

Listed:
  • Seon-Rye Kim

    (Department of Pharmacy, College of Pharmacy, Kangwon National University, Chuncheon-si 24341, Korea)

  • Seoul-Hee Nam

    (Department of Dental Hygiene, College of Health Science, Kangwon National University, 346 Hwangjo-gil, Dogye-up, Samcheok-si, Gangwon-do 25945, Korea
    These authors contributed equally to this work.)

  • Yu-Rin Kim

    (Department of Dental Hygiene, Silla University, 140 Baegyang-daero, 700 beon-gil, Sasang-gu, Busan 46958, Korea
    These authors contributed equally to this work.)

Abstract

10–20% of COVID (Corona Virus Disease)-19 cases proceed to a severe stage, and age and the presence of comorbidity increased the risk of death from COVID-19. The identification of risk factors on progression to the severity stages is essential in providing more efficient and suitable management to COVID-19 patients. However, there is insufficient study on risk factors for severity stages of COVID-19 patients. In this study, 2959 confirmed COVID-19 patients were analyzed while using national data, COVID-19 patients Clinical Epidemiological Information provided from the Korea Disease Control and Prevention Agency. The epidemiological variable, hospital room, periods from confirmation to release, initial symptom and vital signs, underlying comorbidities, and initial blood variables were used to verify the relation with progression to severity stages of COVID-19 and severe COVID-19. The chi-square test, welch test, multiple regression and logistic regression analysis were performed. The ICU (Intensive Care Unit) admission rate of patients having characteristics, such as older age, male, abnormal BMI (Body Mass Index), high heart rate, high body temperature, fever, cough, sputum, sore throat, rhinorrhea, fatigue, dyspnea, change of consciousness, diabetes mellitus, hypertension, chronic artery disease, chronic kidney disease, cancer, dementia, abnormal hemoglobin, abnormal hematocrit, abnormal lymphocyte, abnormal platelets, and abnormal white blood cell were high. The risk factors for severe COVID-19 were older age, shorter hospitalization, abnormal lymphocyte, abnormal platelets, dyspnea, change of consciousness, and dementia. Whereas, significant predictors for progression to severity stages of COVID-19 were older age, longer period from confirmation to release, higher BMI, higher body temperature, abnormal lymphocyte, abnormal platelets, fever, no sore throat, dyspnea, no headache, COPD (Chronic Obstructive Pulmonary Disease), and dementia. Therefore, classifying patients with a high risk of severe stage of COVID-19 and managing patients by considering the risk factors could be helpful in the efficient management of COVID-19 patients.

Suggested Citation

  • Seon-Rye Kim & Seoul-Hee Nam & Yu-Rin Kim, 2020. "Risk Factors on the Progression to Clinical Outcomes of COVID-19 Patients in South Korea: Using National Data," IJERPH, MDPI, vol. 17(23), pages 1-9, November.
  • Handle: RePEc:gam:jijerp:v:17:y:2020:i:23:p:8847-:d:452713
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/23/8847/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/17/23/8847/
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Arben Asllani & Silvana Trimi, 2022. "COVID-19 vaccine distribution: exploring strategic alternatives for the greater good," Service Business, Springer;Pan-Pacific Business Association, vol. 16(3), pages 601-619, September.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:23:p:8847-:d:452713. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.